ReviewCancer chemotherapy and pharmacology2018
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
Larry H Matherly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it